Uveal Melanoma

Uveal Melanoma Research Using Proteomic Methods

Uveal melanoma is the most common intraocular malignancy in adults. The survival rate of uveal melanoma patients who develop metastatic disease is very poor, with few therapeutic options available to treat advanced disease. We are using proteomic methods, e.g. quantitative label-free LC-MS, to understand progression of metastasis in uveal melanoma, using both tissue and vitreous fluid samples from patients with uveal melanoma. This research is being carried out in collaboration with Prof. Susan Kennedy at the Royal Victoria Eye and Ear Hospital, Dublin.


Paula Meleady (paula.meleady@dcu.ie)

Click here to meet our Cancer Research group



Comments are closed.

Chinese (Traditional)EnglishJapanese